CoChat

A Low Tumor Mutational Burden and PTEN Mutations Are Predictors of a Negative Response to PD-1 Blockade in MSI-H/dMMR Gastrointestinal Tumors

Published version of a preprint

The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.

Abstract

Purpose: This study performed a comprehensive molecular characterization of microsatellite instability–high (MSI-H)/mismatch repair–deficient (dMMR) gastrointestinal (GI) tumors to elucidate predictors of response to PD-1 blockade. Experimental Design: Forty-five patients with MSI-H/dMMR GI tumors, including gastric cancer, colorectal cancer, cholangiocarcinoma, small intestine cancer, pancreatic cancer, and duodenal cancer, receiving PD-1 blockade were analyzed. We conducted the genomic profiling of GI tumors by whole-exome sequencing or targeted next-generation sequencing. The tumor microenvironment was evaluated by transcriptomic analysis and multiplex fluorescence IHC. Results: Patients with low tumor mutational burdens (TMBs) had lower objective response rates (ORRs; 0% vs. 48.8%) and a significantly shorter progression-free survival (PFS; 2.3 vs. 15.6 months; HR, 6.20; P = 0.002) than those with high TMBs. Among common gene alterations in GI tumors, only PTEN mutations, which were mutually exclusive with a low TMB, were significantly associated with a lower ORRs than wild-type PTEN (21.4 vs. 54.8%; odds, 4.45; P = 0.045). Compared with wild-type PTEN, PTEN mutations in the phosphatase domain were associated with significantly lower ORRs (12.5 vs. 54.8%; P = 0.049), shorter PFS (2.6 vs. 15.6 months; HR, 5.04; P < 0.001), lower intratumoral CD8+ T-cell levels, higher intratumoral CD204+ macrophage levels, and PI3K/AKT/mTOR pathway enrichment, whereas PTEN mutations in the C2 domain were not. Conclusions: Low TMBs and PTEN mutations, especially mutations in the phosphatase domain associated with an immunosuppressive environment, were mutually exclusive and might be negative predictors of PD-1 blockade responses in patients with MSI-H/dMMR GI tumors.

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-21-0401

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 37 references

Cited by

See all 123

Metadata

Authors
Chida, K., Kawazoe, A., Kawazu, M., Suzuki, T., Nakamura, Y., Nakatsura, T., Kuwata, T., Ueno, T., Kuboki, Y., Kotani, D., Kojima, T., Taniguchi, H., Mano, H., Ikeda, M., Shitara, K., Endo, I., & Yoshino, T.
Affiliations
  • National Cancer Center Hospital East (JP)
  • National Cancer Center Research Institute (JP)
  • National Cancer Center Exploratory Oncology Research & Clinical Trial Center (JP)
  • Yokohama City University (JP)
Venue
Clinical Cancer Research
Published
2021-04-29
Volume
27
Issue
13
Pages
3714-3724
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W3157125484
Cited by
110
References
38
Citations by year
2026: 8 · 2025: 18 · 2024: 21 · 2023: 33 · 2022: 25 · 2021: 5
FWCI
7.64
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Agency for Medical Research and Development (JP19cm0106502)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords
tumor mutational burden, PTEN mutation, anti-PD-1 therapy, microsatellite instability-high, mismatch repair deficiency, gastrointestinal cancer, predictive biomarkers, immunotherapy response, phosphatase domain, tumor immune microenvironment, CD8+ T cells, PI3K/AKT/mTOR pathway, gastric cancer, colorectal cancer, cholangiocarcinoma, pancreatic cancer, duodenal cancer
MeSH terms
Exome Sequencing, Immune Checkpoint Inhibitors, Adult, Aged, Aged, 80 and over, Female, Gastrointestinal Neoplasms, Humans, Male, Middle Aged, Mutation, Retrospective Studies, Treatment Outcome, PTEN Phosphohydrolase, Microsatellite Instability, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Low Tumor Mutational Burden and PTEN Mutations Are Predictors of a Negative Response to PD-1 Blockade in MSI-H/dMMR Gastrointestinal Tumors. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-21-0401
The paper
Chida, K., Kawazoe, A., Kawazu, M., Suzuki, T., Nakamura, Y., Nakatsura, T., Kuwata, T., Ueno, T., Kuboki, Y., Kotani, D., Kojima, T., Taniguchi, H., Mano, H., Ikeda, M., Shitara, K., Endo, I., & Yoshino, T. (2021). A Low Tumor Mutational Burden and PTEN Mutations Are Predictors of a Negative Response to PD-1 Blockade in MSI-H/dMMR Gastrointestinal Tumors. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-21-0401

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.